RecruitingPHASE1, PHASE2NCT06577298

A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
CanSino Biologics Inc.
Principal Investigator
Nina Putri, Dr
Dr. Cipto Mangunkusumo Hospital
Intervention
Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio) low adjuvant dose(biological)
Enrollment
480 target
Eligibility
All sexes
Timeline
20242026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06577298 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials